Hapvida Participações e Investimentos Past Earnings Performance
Past criteria checks 1/6
Hapvida Participações e Investimentos's earnings have been declining at an average annual rate of -58.5%, while the Healthcare industry saw earnings growing at 18.2% annually. Revenues have been growing at an average rate of 32.8% per year. Hapvida Participações e Investimentos's return on equity is 0.1%, and it has net margins of 0.2%.
Key information
-58.5%
Earnings growth rate
-59.9%
EPS growth rate
| Healthcare Industry Growth | 11.6% |
| Revenue growth rate | 32.8% |
| Return on equity | 0.1% |
| Net Margin | 0.2% |
| Last Earnings Update | 30 Sep 2024 |
Recent past performance updates
Recent updates
Hapvida Participações e Investimentos' (BVMF:HAPV3) Performance Is Even Better Than Its Earnings Suggest
Nov 19
Hapvida Participações e Investimentos S.A. (BVMF:HAPV3) Just Reported Third-Quarter Earnings: Have Analysts Changed Their Mind On The Stock?
Nov 15Hapvida Participações e Investimentos (BVMF:HAPV3) Has A Pretty Healthy Balance Sheet
Jul 16Hapvida Participações e Investimentos S.A.'s (BVMF:HAPV3) Popularity With Investors Is Under Threat From Overpricing
Apr 28Is Hapvida Participações e Investimentos (BVMF:HAPV3) A Risky Investment?
Mar 28Investors Still Waiting For A Pull Back In Hapvida Participações e Investimentos S.A. (BVMF:HAPV3)
Jan 07Hapvida Participações e Investimentos (BVMF:HAPV3) Is Making Moderate Use Of Debt
Dec 11Does Hapvida Participações e Investimentos (BVMF:HAPV3) Have A Healthy Balance Sheet?
Sep 11Does Hapvida Participações e Investimentos (BVMF:HAPV3) Have A Healthy Balance Sheet?
Jun 08Here's Why Hapvida Participações e Investimentos (BVMF:HAPV3) Can Afford Some Debt
Feb 27Hapvida Participações e Investimentos (BVMF:HAPV3) Has A Somewhat Strained Balance Sheet
Nov 11At R$8.13, Is It Time To Put Hapvida Participações e Investimentos S.A. (BVMF:HAPV3) On Your Watch List?
Sep 11Here's Why Hapvida Participações e Investimentos (BVMF:HAPV3) Has A Meaningful Debt Burden
Jul 08Is Now The Time To Look At Buying Hapvida Participações e Investimentos S.A. (BVMF:HAPV3)?
Mar 27We Think Hapvida Participações e Investimentos (BVMF:HAPV3) Is Taking Some Risk With Its Debt
Dec 28Is Now The Time To Look At Buying Hapvida Participações e Investimentos S.A. (BVMF:HAPV3)?
Nov 23Does Hapvida Participações e Investimentos (BVMF:HAPV3) Have A Healthy Balance Sheet?
Sep 10Should You Think About Buying Hapvida Participações e Investimentos S.A. (BVMF:HAPV3) Now?
Aug 06Does Hapvida Participações e Investimentos (BVMF:HAPV3) Have A Healthy Balance Sheet?
May 12The Hapvida Participações e Investimentos S.A. (BVMF:HAPV3) Annual Results Are Out And Analysts Have Published New Forecasts
Mar 20Introducing Hapvida Participações e Investimentos (BVMF:HAPV3), A Stock That Climbed 55% In The Last Year
Mar 10Hapvida Participações e Investimentos (BVMF:HAPV3) Has A Pretty Healthy Balance Sheet
Feb 11
Is Hapvida Participações e Investimentos S.A.'s (BVMF:HAPV3) Recent Stock Performance Influenced By Its Fundamentals In Any Way?
Jan 07Revenue & Expenses Breakdown
How Hapvida Participações e Investimentos makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 30 Sep 24 | 28,801 | 53 | 1,526 | 0 |
| 30 Jun 24 | 27,335 | -555 | 1,410 | 0 |
| 31 Mar 24 | 27,976 | -461 | 1,401 | 0 |
| 31 Dec 23 | 27,770 | -759 | 1,543 | 0 |
| 30 Sep 23 | 15,641 | -1,993 | 17 | 0 |
| 30 Jun 23 | 15,080 | -1,751 | 214 | 0 |
| 31 Mar 23 | 20,085 | -1,776 | 1,336 | 0 |
| 31 Dec 22 | 23,812 | -1,720 | 2,004 | 0 |
| 30 Sep 22 | 19,845 | -261 | 5,177 | 0 |
| 30 Jun 22 | 16,083 | -252 | 4,049 | 0 |
| 31 Mar 22 | 12,402 | 166 | 3,079 | 0 |
| 31 Dec 21 | 9,883 | 498 | 2,554 | 0 |
| 30 Sep 21 | 9,558 | 389 | 2,451 | 0 |
| 30 Jun 21 | 9,125 | 595 | 2,307 | 0 |
| 31 Mar 21 | 8,799 | 769 | 2,163 | 0 |
| 31 Dec 20 | 8,555 | 783 | 2,071 | 0 |
| 30 Sep 20 | 8,067 | 901 | 1,769 | 0 |
| 30 Jun 20 | 7,256 | 865 | 1,590 | 0 |
| 31 Mar 20 | 6,456 | 809 | 1,329 | 0 |
| 31 Dec 19 | 5,634 | 850 | 1,118 | 0 |
| 30 Sep 19 | 5,060 | 875 | 982 | 0 |
| 30 Jun 19 | 4,908 | 852 | 898 | 0 |
| 31 Mar 19 | 4,411 | 714 | 852 | 0 |
| 31 Dec 18 | 4,576 | 787 | 951 | 0 |
| 30 Sep 18 | 4,408 | 1,201 | 835 | 0 |
| 31 Mar 18 | 4,383 | 768 | 796 | 0 |
| 31 Dec 17 | 3,848 | 649 | 805 | 0 |
| 31 Dec 16 | 3,036 | 457 | 680 | 0 |
| 31 Dec 15 | 2,459 | 301 | 617 | 0 |
| 31 Dec 14 | 1,964 | 270 | 437 | 0 |
Quality Earnings: HAPV3 has a large one-off loss of R$577.5M impacting its last 12 months of financial results to 30th September, 2024.
Growing Profit Margin: HAPV3 became profitable in the past.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: HAPV3's earnings have declined by 58.5% per year over the past 5 years.
Accelerating Growth: HAPV3 has become profitable in the last year, making the earnings growth rate difficult to compare to its 5-year average.
Earnings vs Industry: HAPV3 has become profitable in the last year, making it difficult to compare its past year earnings growth to the Healthcare industry (64.3%).
Return on Equity
High ROE: HAPV3's Return on Equity (0.1%) is considered low.